(MedPage Today) — FDA leaders claimed that publishing hundreds of complete response letters (CRLs) in a central database was embracing “radical transparency,” but critics think the move was more about optics, and argue the agency has bigger transparency…
Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/116544
Author :
Publish date : 2025-07-17 16:10:00
Copyright for syndicated content belongs to the linked Source.
